Rilatine Modified Release 10 mg hard caps. modif.-rel. Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rilatine modified release 10 mg hard caps. modif.-rel.

infectopharm arzneimittel und consilium gmbh - methylphenidate hydrochloride 10 mg - modified-release capsule, hard - 10 mg - methylphenidate hydrochloride 10 mg - methylphenidate

Ritalin XL 10mg capsules Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

ritalin xl 10mg capsules

infectopharm arzneimittel und consilium gmbh - methylphenidate hydrochloride - modified-release capsule - 10mg

Ritalin XL 20mg capsules Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

ritalin xl 20mg capsules

infectopharm arzneimittel und consilium gmbh - methylphenidate hydrochloride - modified-release capsule - 20mg

Ritalin XL 30mg capsules Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

ritalin xl 30mg capsules

infectopharm arzneimittel und consilium gmbh - methylphenidate hydrochloride - modified-release capsule - 30mg

Ritalin XL 60mg capsules Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

ritalin xl 60mg capsules

infectopharm arzneimittel und consilium gmbh - methylphenidate hydrochloride - modified-release capsule - 60mg

Ritalin XL 40mg capsules Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

ritalin xl 40mg capsules

infectopharm arzneimittel und consilium gmbh - methylphenidate hydrochloride - modified-release capsule - 40mg

ADRENALIN 1:1000 INFECTOPHARM 1 mg/mL Solution for Injection Málta - angol - Medicines Authority

adrenalin 1:1000 infectopharm 1 mg/ml solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - epinephrine - solution for injection - epinephrine 1 mg - cardiac therapy

FOMICYT 2 G. Izrael - angol - Ministry of Health

fomicyt 2 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 2 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.

FOMICYT 4 G. Izrael - angol - Ministry of Health

fomicyt 4 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 4 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.

FOMICYT 8 G. Izrael - angol - Ministry of Health

fomicyt 8 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 8 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.